前体指导的生物合成和生物活性的三白Cpip,一个新的三白C类比含有pipecolic酸
Hideki Hashizume1, Ryuichi Sawa2, Yumiko Kubota2
1Laboratory of Microbiology, Institute of Microbial Chemistry (BIKAKEN), Tokyo, 3-14-23 Kamiosaki, Shinagawa-ku, Tokyo, 141-0021, Japan. hashizumeh@bikaken.or.jp.
The Journal of antibiotics
|January 24, 2024
概括
三烯C中的L-prolyl-D-proline结构对其强大的抗菌活性至关重要,这种抗菌活性对抗了耐甲林耐药性黄金葡萄球菌等细菌. 取而代之的普罗林与pipecolic 酸削弱了它的有效性.
科学领域:
- 微生物学 微生物学
- 药用化学 医学化学
- 生物化学 生化学
背景情况:
- 三烯C是一种循环脂,对抗抗甲素耐药黄金葡萄球菌 (MRSA) 有强烈的疗效.
- 三烯含有L-prolyl-D-proline基结构,已知可以诱导中的毛结构.
- 这种基结构对抗菌活性的贡献以前是未知的.
研究的目的:
- 调查L-prolyl-D-proline基结构在三烯酸C的抗菌活性中的作用.
- 为了合成和表征用修饰的氨酸残留物合成和表征trippropeptin类似物.
主要方法:
- 使用前体指导生物合成,用pipecolic酸替换trippropeptin C中的proline残留物.
- 分离和净化由此产生的三白类似物,三白Cpip.
- 在体外对抗微生物敏感性测试,对包括MRSA在内的格拉姆阳性细菌进行检测.
主要成果:
- 含有一种L-pipecolic酸而不是L-proline的Tripropeptin Cpip,已成功合成.
- 三烯Cpip表现出降低的抗菌活性,比三烯C弱两到四倍.
- 对标准和耐药的格拉姆阳性细菌菌株均观察到活性下降.
结论:
- L-prolyl-D-proline基结构对于trippropeptin C的高强度至关重要.
- 对这种特定基结构的修改会显著影响抗菌疗效.
- 这些发现提供了关于三烯的结构-活性关系的见解,指导未来的抗生素开发.
相关概念视频
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Phosphoinositides and PIPs
8.5K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K
Insulin: Biosynthesis, Chemistry, and Preparation
382
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
382
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Glucagon-like Receptor Agonists
323
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
323
IP3/DAG Signaling Pathway
12.1K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.1K


